RecruitingSpinal DeformitySpinal Degenerative DisorderSpinal Fusion Failure
The Ailliance Post-Market Clinical Study
Eligible age
18+ yrs
Accepts
All genders
Locations
17 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.
Sponsor: Medtronic Spinal and Biologics
You may qualify if…
- ✓ 1. Subject provides written informed consent per institution and/or geographical requirements.
- ✓ 2. Subject is intended to receive or be treated with an eligible Medtronic Cranial and Spinal Technology (CST) device(s) (see product appendices), used alone or in combination, for a cranial and/or spinal indication(s).
- ✓ 3. Subject is at least 18 years of age or minimum legal age as required by local regulations.
- ✓ 4. Subject agrees to complete all required assessments per the Schedule of Events.
You may not qualify if…
- ✕ 1. Subject is currently enrolled or plans to enroll in concurrent drug/device/biologic trial(s) that may confound this trial's results per investigator assessment (i.e. no required intervention that could affect interpretation of all-around device safety and or performance).
- ✕ 2. Subject who is, or is expected to be, inaccessible for all required follow-up visits.
- ✕ 3. Subject with exclusion criteria required by local law.
- ✕ 4. Subject is considered vulnerable at the time of obtaining consent.
Where it's recruiting
Source: ClinicalTrials.gov · NCT05856370 · last updated 2026-08-17